Bayard R. Huck,Erik Wilker,Andreas Machl,Remigiusz Kaleta
申请号：
US15128045
公开号：
US09980966B2
申请日:
2015.03.09
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to combinations of 4-[(S)-2-Azetidin-1-yl-1-(4-chloro-3-trifluoromethyl-phenyl)-ethylamino]-quinazoline-8-carboxylic acid amide and/or its physiologically acceptable salts and solvates, and an inhibitor of Her2, and the use of such combinations for the treatment of cancer.
